Jim Gearhart

by Jim Gearhart

Week in Review (March 20, 2015)

Happy Friday, and First Day of Spring.

Here are some of the week’s highlights from the world of medical research:

In Southern California, researchers have matched improvements in health with 30 years of improved air quality.

FDA Director Dr. Hamburg made her last presentation to the Senate Committee on Health, Education, Labor, and Pensions. Her speech included a look at FDA’s improved rate of product approvals.

Mushrooms + Manure = A new antibiotic? Researchers have found potential for a powerful antibiotic in a pile of horse manure.

The New York Times considers how mobile apps for health are performing.

Biogen has an Alzheimer’s Drug in Phase I that may be reversing cognitive decline better than other treatments.

A Duke University team finds that the private sector is doing a better job than the public sector at reporting results to clinicaltrials.gov.

And a team at McGill found that stalled drug trials contain many undisclosed but useful insights.

GlaxoSmithKline announces R&D and other staff cuts in Philadelphia. This adds to reductions GSK has planned for its North Carolina operations.

Tags: , , ,